Evidence map›Paper›PMID 28454988›Full record

ArticleUrology2017

Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer.

Kimberly Davis, Paula Bellini, Charlotte Hagerman, Riley Zinar, Daniel Leigh, Richard Hoffman, David Aaronson, Stephen Van Den Eeden, George Philips, Kathryn Taylor

Abstract readMulticenter Study
In one paragraph

Article in Urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Kimberly DavisDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC. Electronic address: kmd54@georgetown.edu.
Paula BelliniDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC.
Charlotte HagermanDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC.
Riley ZinarDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC.
Daniel LeighDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC.
Richard HoffmanDivision of General Internal Medicine, University of Iowa Carver College of Medicine/Iowa City VA Medical Center, Iowa City, IA.
David AaronsonDepartment of Urology, Kaiser Permanente, East Bay, Oakland, CA.
Stephen Van Den EedenDivision of Research, Kaiser Permanente Northern California, Oakland, CA.
George PhilipsDepartment of Medicine, MedStar Georgetown University Hospital Center, Washington, DC.
Kathryn TaylorDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, DC.

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Maximiliano A DAngelo · 1985 to 2026
$107.2M
Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Mark E Burkard · 2000 to 2026
$70.0M
TREATMENT DECISIONS AND PATIENT REPORTED OUTCOMES IN LOW RISK PROSTATE CANCERR01CA155578 · NCI · GEORGETOWN UNIVERSITY · PI TAYLOR, KATHRYN L, VAN DEN EEDEN, STEPHEN K. · 2011 to 2015
$3.1M
NCI NIH HHS P30 CA086862NCI NIH HHS R01 CA155578
6 · The paper itself

Abstract

objectiveTo assess physicians' attitudes regarding multiple factors that may influence recommendations for active surveillance (AS) vs active treatment (AT) given the central role physicians play in the treatment decision-making process. MATERIALS AND

methodsWe conducted semistructured interviews to assess factors that physicians consider important when recommending AS vs AT, as well as physicians' perceptions of what their patients consider important in the decision. Participants included urologists (N = 11), radiation oncologists (N = 12), and primary care physicians (N = 10) from both integrated and fee-for-service healthcare settings.

resultsAcross the specialties, quantitative data indicated that most physicians reported that their recommendations for AS were influenced by patients' older age, willingness and ability to follow a surveillance protocol, anxiety, comorbidities, life expectancy, and treatment preferences. Qualitative findings highlighted physicians' concerns about malpractice lawsuits, given the possibility of disease progression. Additionally, most physicians noted the role of the healthcare setting, suggesting that financial incentives may be associated with AT recommendations in fee-for-service settings. Finally, most physicians reported spouse or family opposition to AS due to their own anxiety or lack of understanding of AS.

conclusionWe found that patient and physician preferences, healthcare setting, and family or spouse factors influence physicians' treatment recommendations for men with low-risk PCa. These were consistent themes across physician subspecialties in both an Health Maintenance Organization and in fee-for-service settings.

Indexed as

Attitude of Health PersonnelDecision MakingPerceptionPhysician's RoleAdultCombined Modality TherapyHumansMaleMiddle AgedPhysiciansPractice Patterns, Physicians'Prostatic NeoplasmsSurveys and QuestionnairesUnited States

Identifiers

PMID28454988
PMCPMC5880528

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.